149. Immunogenicity, Safety, and Post-hoc Efficacy Assessment of the Adjuvanted Recombinant Zoster Vaccine in Adults with Hematologic Malignancies: A Phase 3, Randomized Clinical T...

por Dagnew, Alemnew F, Ilhan, Osman, Lee, Won-Sik, Woszczyk, Dariusz, Kwak, Jae-Yong, Bowcock, Stella, Sohn, Sang Kyun, Rodriguez Macías, Gabriela, Chiou, Tzeon-Jye, Quiel, Dimas, Aoun, Mickael, Matilla, Maria Belen Navarro, De La Serna, Javier, Milliken, Samuel, Murphy, John, McNeil, Shelly A, Salaun, Bruno, Paolo, Emmanuel Di, Campora, Laura, López-Fauqued, Marta, El Idrissi, Mohamed, Schuind, Anne, Heineman, Thomas C, Van Den Steen, Peter, Oostvogels, Lidia
Publicado 2018

2483. Twelve-Month Immunogenicity and Safety of an Adjuvanted Recombinant Zoster Vaccine in Immunosuppressed Adults Post Renal Transplant: a Phase III Randomized Clinical Trial

por Vink, Peter, Torrell, Josep Maria Ramon, Sanchez-Fructuoso, Ana I, Kim, Sung-Joo, Kim, Sang Il, Zaltzman, Jeffrey, Ortiz, Fernanda, Plana, Josep Maria Campistol, Rodriguez, Ana Maria Fernandez, Rodrigo, Henar Rebollo, Marti, Magda Campins, Perez, Rafael, González-Roncero, Francisco Manuel, Kumar, Deepali, Chiang, Yang-Jen, Doucette, Karen, Pipeleers, Lissa, Morales, Maria Luisa Agüera, Ferrero, Maria Luisa Rodriguez, Secchi, Antonio, McNeil, Shelly A, Campora, Laura, Paolo, Emmanuel Di, Idrissi, Mohamed El, López-Fauqued, Marta, Salaun, Bruno, Heineman, Thomas, Oostvogels, Lidia
Publicado 2018